Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
These 2 Biotech Stocks Are Set To Split The $15 Billion Hepatitis C Market
Yahoo/Benzinga
Sat, 12/13/14 - 11:29 am
Gilead Sciences
AbbVie
hepatitis
hepatitis C
These 2 Biotech Stocks Are Set To Split The $15 Billion Hepatitis C Market
Yahoo/Benzinga
Fri, 12/12/14 - 07:17 pm
hepatitis C
Gilead Sciences
Sovaldi
Harvoni
AbbVie
Why Gilead Sciences and AbbVie Care About This Tiny Company
Motley Fool
Thu, 12/11/14 - 10:32 am
AbbVie
Gilead Sciences
Achillion
hepatitis C
Gilead Sciences: Still Waiting on AbbVie
Barron's
Tue, 12/9/14 - 04:03 pm
Gilead Sciences
AbbVie
hepatitis C
Gilead Sciences: Time to Look Beyond Hepatitis C?
Barron's
Fri, 12/5/14 - 10:30 am
Gilead Sciences
hepatitis C
Sovaldi Versus Abbvie Combination: Analysis Of Abbvie Combination Impact On Sovaldi Market Share
Seeking Alpha
Tue, 12/2/14 - 08:54 am
Sovaldi
AbbVie
Gilead Sciences
hepatitis C
Why Gilead Sciences, Inc. Stock Lost 10% in November
Motley Fool
Tue, 12/2/14 - 08:49 am
Gilead Sciences
Sovaldi
Harvoni
hepatitis C
Mylan to Manufacture, Distribute Gilead Sciences HIV Drug
Marketwatch
Mon, 12/1/14 - 09:58 am
Mylan Labs
HIV
Gilead Sciences
tenofovir
Gilead Sciences: New Prescriptions for Hepatitis C Drugs Slow
Barron's
Sat, 11/29/14 - 10:27 am
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Gilead Sciences (GILD) Stock Falls On Rumors Of Icahn’s Stake In The Company
Bidness Etc.
Fri, 11/21/14 - 08:27 am
Gilead Sciences
Carl Icahn
Biotech's 3 Most Influential CEOs
Motley Fool
Thu, 11/20/14 - 10:54 am
biotech
Ivax
Teva Pharmaceutical
Phillip Frost
OPKO Health
Chris Viehbacher
Sanofi
Gilead Sciences
John C. Martin
Gilead Sciences: The Worst Case Scenario?
Barron's
Wed, 11/19/14 - 05:31 pm
Gilead Sciences
hepatitis C
Harvoni
Sovaldi
Go-go execs at Gilead nab an FDA priority review voucher for $125M
Fierce Biotech
Wed, 11/19/14 - 08:53 am
FDA
Gilead Sciences
priority review
Gilead Sciences (GILD) Stock Rises After European Commission Market Authorization for Harvoni
TheStreet.com
Tue, 11/18/14 - 10:59 am
Gilead Sciences
Harvoni
Europe
hepatitis C
Gilead: What About Its Pipeline?
Barron's
Mon, 11/17/14 - 10:52 am
Gilead Sciences
hepatitis C
Can Gilead Double From Here?
Forbes
Fri, 11/14/14 - 09:51 am
Gilead Sciences
4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic
24/7 Wall St
Thu, 11/13/14 - 09:34 am
hepatitis C
AbbVie
Achillion
Gilead Sciences
Merck
Gilead hepatitis C drug highly effective in cirrhosis patients
Yahoo/Reuters
Tue, 11/11/14 - 01:14 pm
Gilead Sciences
cirrhosis
Harvoni
Are Expensive Biotech Drugs Bad For Business?
Seeking Alpha
Tue, 11/11/14 - 10:53 am
drug pricing
biotech
AbbVie
AstraZeneca
Bristol-Myers Squibb
Dendreon
Gilead Sciences
GSK
Merck
Novartis
Teva Pharmaceutical
Vertex Pharmaceuticals
Achillion Pharmaceuticals (ACHN): A Potential Acquisition Target For Gilead Sciences (GILD)
Bidness Etc.
Tue, 11/11/14 - 10:32 am
Achillion
M&A
Gilead Sciences
hepatitis C
Pages
« first
‹ previous
…
67
68
69
70
71
72
73
74
75
…
next ›
last »